AIMI - AIM ImmunoTech Inc.
10.15
0.650 6.404%
Share volume: 97,105
Last Updated: 06-17-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$9.50
0.65
0.07%
View ratios
| Fiscal Date | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|
| Fiscal Quarter | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-15-2025 | 08-14-2025 | 11-17-2025 | |
| Assets | ||||
| Total Assets | 6.248 M | 4.129 M | 5.494 M | |
| Current Assets | 2.584 M | 1.025 M | 2.575 M | |
| Inventories | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 1.349 M | 359.000 K | 62.000 K | |
| Total Receivables | 0.000 | 0.000 | 0.000 | |
| Current Cash | 898.000 K | 476.000 K | 2.347 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 98.000 K | 89.000 K | 80.000 K | |
| Other Assets | 3.566 M | 3.015 M | 2.839 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||
| Total Liabilities and shareholders’ equity | 6.248 M | 4.129 M | 5.494 M | |
| Total liabilities | 10.105 M | 10.675 M | 11.571 M | |
| Total current liabilities | 9.767 M | 10.393 M | 4.043 M | |
| Accounts Payable | 6.944 M | 7.297 M | 1.252 M | |
| Other liabilities | 338.000 K | 282.000 K | 7.528 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 338.000 K | 282.000 K | 7.528 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -3.857 M | -6.546 M | -6.077 M | |
| Common stock | 426.676 M | 426.781 M | 430.534 M | |
| Retained earnings | -430.533 M | -433.327 M | -436.611 M |